Use access key #2 to skip to page content.
  • S&P 500: 1,070.52
  • Change: 1.30%
$57.10 0.18 (0.32%)
2/9/2010 4:00 PM

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

CAPS Rating:
*****

A global pharmaceutical company, which develops, produces and markets generic drugs covering all major treatment categories.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating TEVA

Add Stock to Watchlist

What the Community Thinks

Total Members

1512 Outperforms
56 Underperforms
 

All-Stars

426 Outperforms
10 Underperforms
 

Wall Street

21 Outperforms
0 Underperforms
 

Members bullish on TEVA are also bullish on:

Members bearish on TEVA are also bearish on:

Ticker Tags

Defensive (1457), Growth (1902), Nasdaq 100 (85), Healthcare (711), Mega Cap (110), Drugs - Generic (3), International Stock (684), Aggressive Growth (860), Israel (26), Pharmaceuticals (149)
Suggest a tag

Teva Pharmaceutical Industries Ltd (ADR) At A Glance

Current Price: $57.10
Last Trade Time: 2/9/2010 4:00 PM
Open: $0.00
Previous Close: $56.92
Daily Range: $56.72 - $57.59
52-Week Range: $41.70 - $59.62
Volume: 4,539,657
Market Cap: $52.08B
P/E Ratio: 58.08
Compare Our Special Broker Offers!

Stock Trends

TEVA VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for TEVA

More Headlines...

Top Bull Pitch

Recs

2

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

Avatar shreebs (59.99) Submitted: 8/17/09 4:40 AM

Extremely defensive and while the bad news on Barr will hurt the mkt will overeact and then come running back to Teva to find a place to hide from the coming correction.

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Teva Pharmaceutical Industries Ltd (ADR) (TEVA)

Avatar dvd3434 (22.62) Submitted: 7/21/07 5:55 AM

will go down to 38-39$ to check the lows and than will go up again

Replies: 1 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 273 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (TEVA)

Avatar judged333 (27.96) Submitted: 2/04/10 10:46 AM : Outperform Start Price: $57.55 TEVA Score: -0.30

generics is the future.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TEVA)

Avatar mosstrader (43.15) Submitted: 2/03/10 7:10 PM : Outperform Start Price: $57.64 TEVA Score: 0.68

Say no more

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TEVA)

Avatar SoCalBigDog (53.09) Submitted: 2/02/10 11:56 PM : Outperform Start Price: $57.85 TEVA Score: 1.12

Can you say Obama!!!!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TEVA)

Avatar TMFQue (98.06) Submitted: 2/01/10 11:39 AM : Outperform Start Price: $56.41 TEVA Score: 2.52

Stocks 360

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (TEVA)

Avatar TMFPhillyDot (89.85) Submitted: 1/27/10 3:20 PM : Outperform Start Price: $57.75 TEVA Score: 4.13

Teva has a near strangle hold on the generics market, which should help them to aggressively boost revenues over the next 5-10 years.

Analysts are often hesitant b/c Teva's MS drug, Copaxone, may see generic competition from Mylan. I think this is already baked into the stock price. However, I think there will be either two outcomes: (1) Mylan won't be able to bring the drug to market (as Teva claims), or (2) even if they do, Teva should be coming out with an oral version of Copaxone within the next year or two. My mother has MS and I physically give her Copaxone shots, and I see the devastating effects of injections. An oral form of Copaxone would be absolutely huge for Teva and for MS patients in general. I think the market underestimates the upside.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 273 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 21 of 21  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackJimCramer < 20 07/23/09 Outperform 3W $49.95+14.31%+10.31%+4.00
TrackHeebner 34.75 06/29/09 Outperform 5Y $48.52+17.69%+16.93%+0.75 Toggle the visibility of 60-Second Pitch and replies
TrackBarclaysCap 94.50 05/28/09 Outperform NS $45.88+24.45%+19.77%+4.69
TrackZacks 62.21 04/24/09 Outperform 3M $44.14+29.36%+25.02%+4.34 Toggle the visibility of 60-Second Pitch and replies
TrackJefferies 82.08 04/23/09 Outperform NS $43.13+32.40%+27.91%+4.49
TrackWayneRogers < 20 03/13/09 Outperform 3M $45.05+26.74%+43.40%-16.66
TrackTobinSmith < 20 02/20/09 Outperform 1Y $45.71+24.93%+40.93%-16.00
TrackJPMorgan 84.76 12/17/08 Outperform NS $42.53+34.26%+21.09%+13.17
TrackCitigroup 85.92 12/17/08 Outperform NS $42.53+34.26%+21.09%+13.17
TrackStanfordRes 85.54 09/25/08 Outperform NS $44.69+27.78%-7.95%+35.73
TrackNeedham 67.64 09/25/08 Outperform NS $44.69+27.78%-7.95%+35.73
TrackWellsFargo 80.02 09/22/08 Outperform NS $45.73+24.85%-11.71%+36.56
TrackOppenheimer 81.36 09/11/08 Outperform NS $45.09+26.63%-9.40%+36.03
TrackDeutscheSec 89.68 07/21/08 Outperform NS $42.81+33.39%-12.50%+45.89
TrackHSBC 86.09 06/30/08 Outperform NS $44.57+28.11%-13.52%+41.63
TrackBofASec 94.61 12/18/07 Outperform NS $43.38+31.62%-23.11%+54.73
TrackBearStearns 84.85 07/09/07 Outperform NS $40.36+41.47%-26.11%+67.58
TrackCreditSuiss 93.62 06/06/07 Outperform NS $38.63+47.82%-25.87%+73.69
TrackUBS 87.99 03/23/07 Outperform NS $36.41+56.83%-20.90%+77.73
TrackScottBleier 91.98 12/16/06 Outperform 3M $31.25+82.69%-20.05%+102.74
TrackGaryBSmith 74.46 08/04/06 Outperform 3W $33.37+71.14%-10.84%+81.98

Results 1 - 21 of 21  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEBD01 875ms